↓ Skip to main content

Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

Overview of attention for article published in Journal of Clinical Oncology, August 2013

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Readers on

mendeley
169 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 169 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Ecuador 2 1%
Japan 1 <1%
France 1 <1%
Unknown 165 98%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 27 16%
Other 24 14%
Student > Ph. D. Student 18 11%
Student > Master 16 9%
Student > Bachelor 13 8%
Other 21 12%
Unknown 50 30%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 57 34%
Agricultural and Biological Sciences 23 14%
Biochemistry, Genetics and Molecular Biology 18 11%
Nursing and Health Professions 4 2%
Economics, Econometrics and Finance 2 1%
Other 9 5%
Unknown 56 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 128. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 October 2022.
All research outputs
#388,006
of 31,702,978 outputs
Outputs from Journal of Clinical Oncology
#739
of 29,529 outputs
Outputs of similar age
#2,363
of 230,077 outputs
Outputs of similar age from Journal of Clinical Oncology
#4
of 222 outputs
Altmetric has tracked 31,702,978 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 29,529 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.8. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 230,077 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 222 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.